Jae Seon Eo1, Ho-Young Lee2, Jae Sung Lee3, Yu Kyung Kim4, Bum-Seok Jeon5, Dong Soo Lee6. 1. Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehang-ro, Jongro-gu, Seoul, 110-744 Korea ; Department of Nuclear Medicine, Korea University Anam Hospital, Seoul, Korea. 2. Department of Nuclear Medicine, Seoul National University Bundang Hospital, Gyeonggi-do, Korea. 3. Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehang-ro, Jongro-gu, Seoul, 110-744 Korea. 4. Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehang-ro, Jongro-gu, Seoul, 110-744 Korea ; Department of Nuclear Medicine, Boramae Medical Center, Seoul, Korea. 5. Department of Neurology, Seoul National University College of Medicine, Seoul, Korea. 6. Department of Nuclear Medicine, Seoul National University College of Medicine, 101 Daehang-ro, Jongro-gu, Seoul, 110-744 Korea ; Department of Molecular Medicine and Biopharmaceutical Sciences, Seoul National University, Seoul, Korea.
Abstract
BACKGROUND: Population-based statistical probabilistic anatomical maps have been used to generate probabilistic volumes of interest for analyzing perfusion and metabolic brain imaging. We investigated the feasibility of automated analysis for dopamine transporter images using this technique and evaluated striatal binding potentials in Parkinson's disease and Wilson's disease. MATERIALS AND METHODS: We analyzed 2β-Carbomethoxy-3β-(4-(123)I-iodophenyl)tropane ((123)I-beta-CIT) SPECT images acquired from 26 people with Parkinson's disease (M:F = 11:15, mean age = 49 ± 12 years), 9 people with Wilson's disease (M: F = 6:3, mean age = 26 ± 11 years) and 17 normal controls (M:F = 5:12, mean age = 39 ± 16 years). A SPECT template was created using striatal statistical probabilistic map images. All images were spatially normalized onto the template, and probability-weighted regional counts in striatal structures were estimated. The binding potential was calculated using the ratio of specific and nonspecific binding activities at equilibrium. Voxel-based comparisons between groups were also performed using statistical parametric mapping. RESULTS: Qualitative assessment showed that spatial normalizations of the SPECT images were successful for all images. The striatal binding potentials of participants with Parkinson's disease and Wilson's disease were significantly lower than those of normal controls. Statistical parametric mapping analysis found statistically significant differences only in striatal regions in both disease groups compared to controls. CONCLUSION: We successfully evaluated the regional (123)I-beta-CIT distribution using the SPECT template and probabilistic map data automatically. This procedure allows an objective and quantitative comparison of the binding potential, which in this case showed a significantly decreased binding potential in the striata of patients with Parkinson's disease or Wilson's disease.
BACKGROUND: Population-based statistical probabilistic anatomical maps have been used to generate probabilistic volumes of interest for analyzing perfusion and metabolic brain imaging. We investigated the feasibility of automated analysis for dopamine transporter images using this technique and evaluated striatal binding potentials in Parkinson's disease and Wilson's disease. MATERIALS AND METHODS: We analyzed 2β-Carbomethoxy-3β-(4-(123)I-iodophenyl)tropane ((123)I-beta-CIT) SPECT images acquired from 26 people with Parkinson's disease (M:F = 11:15, mean age = 49 ± 12 years), 9 people with Wilson's disease (M: F = 6:3, mean age = 26 ± 11 years) and 17 normal controls (M:F = 5:12, mean age = 39 ± 16 years). A SPECT template was created using striatal statistical probabilistic map images. All images were spatially normalized onto the template, and probability-weighted regional counts in striatal structures were estimated. The binding potential was calculated using the ratio of specific and nonspecific binding activities at equilibrium. Voxel-based comparisons between groups were also performed using statistical parametric mapping. RESULTS: Qualitative assessment showed that spatial normalizations of the SPECT images were successful for all images. The striatal binding potentials of participants with Parkinson's disease and Wilson's disease were significantly lower than those of normal controls. Statistical parametric mapping analysis found statistically significant differences only in striatal regions in both disease groups compared to controls. CONCLUSION: We successfully evaluated the regional (123)I-beta-CIT distribution using the SPECT template and probabilistic map data automatically. This procedure allows an objective and quantitative comparison of the binding potential, which in this case showed a significantly decreased binding potential in the striata of patients with Parkinson's disease or Wilson's disease.
Authors: G Lucignani; C Gobbo; R M Moresco; A Antonini; A Panzacchi; L Bonaldi; A Carpinelli; T Caraceni; F Fazio Journal: Nucl Med Commun Date: 2002-11 Impact factor: 1.690
Authors: Michael Nocker; Klaus Seppi; Eveline Donnemiller; Irene Virgolini; Gregor K Wenning; Werner Poewe; Christoph Scherfler Journal: Eur J Nucl Med Mol Imaging Date: 2012-03-30 Impact factor: 9.236
Authors: C H van Dyck; J P Seibyl; R T Malison; M Laruelle; E Wallace; S S Zoghbi; Y Zea-Ponce; R M Baldwin; D S Charney; P B Hoffer Journal: J Nucl Med Date: 1995-07 Impact factor: 10.057